Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders' Equity Statement

v3.21.1
Condensed Consolidated Statements of Stockholders' Equity Statement - USD ($)
Total
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Noncontrolling Interest
Beginning balance (shares) at Dec. 31, 2019   24,849,261      
Beginning balance at Dec. 31, 2019 $ 23,353,277 $ 24,849 $ 56,622,285 $ (33,379,114) $ 85,257
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock options (shares)   1,000      
Exercise of stock options 1,200 $ 1 1,199    
Stock issuance costs (401)   (401)    
Stock based compensation expense 42,236   42,236    
Distributions to non-controlling interest (23,070)        
Distributions to Noncontrolling interests (23,070)        
Net income (loss) (1,202,387)     (1,202,387)  
Net loss (11,808)       (11,808)
Net income (loss) (1,190,579)        
Ending balance (shares) at Mar. 31, 2020   24,850,261      
Ending balance at Mar. 31, 2020 22,182,663 $ 24,850 56,665,319 (34,581,501) 73,995
Beginning balance (shares) at Dec. 31, 2020   24,850,261      
Beginning balance at Dec. 31, 2020 17,267,334 $ 24,850 56,814,428 (39,529,621) (42,323)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock based compensation expense 39,085   39,085    
Distributions to non-controlling interest (18,176)        
Distributions to Noncontrolling interests (18,176)        
Net income (loss) 1,766,707     1,766,707  
Net loss (11,796)       (11,796)
Net income (loss) 1,778,503        
Ending balance (shares) at Mar. 31, 2021   24,850,261      
Ending balance at Mar. 31, 2021 $ 19,066,746 $ 24,850 $ 56,853,513 $ (37,762,914) $ (48,703)